Brimonidine Tartrate Ophthalmic Solution

DRUG3 trials

Sponsors

Alcon Research, Allergan, Sun Pharma Advanced Research Company Limited

Conditions

GlaucomaOcular HypertensionOpen Angle GlaucomaOpen-Angle Glaucoma

Phase 3

A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT00061529

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2003-01-31End: 2004-07-31Updated: 2008-08-05

Evaluation of Safety and Efficacy of PDP-716

CompletedNCT03450629

Sun Pharma Advanced Research Company LimitedOcular Hypertension, Open Angle Glaucoma

Start: 2018-09-13End: 2020-12-01Updated: 2022-02-15

Unknown Phase

Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

CompletedNCT01229462

AllerganGlaucoma, Ocular Hypertension

Start: 2010-10-31End: 2011-09-30Updated: 2012-09-14